13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$214.3M
$214.3M
34 檔
46.4%
As reported in its official Q1 2024 Form 13F filing, Knoll Capital Management, LLC's tracked investment portfolio stood at $214.3M with 34 total positions.
In Q1 2024, Knoll Capital Management, LLC displayed an active expansion posture, initiating 5 new positions and adding to 5 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | APLT | Applied Therapeutics Inc | Stock-Other | 23.58% | — | +1.83% | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 16.69% | +5.40% | — | |
| 3 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 11.14% | +0.30% | — | |
| 4 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 6.30% | — | — | |
| 5 | GLD | Spdr Gold Shares | ETF-Commodities | 4.10% | — | — | |
| 6 | ✓ | Entera Bio LTD | Stock-Other | 4.03% | +1.27% | — | |
| 7 | ALT | Altimmune Inc | Stock-Other | 3.59% | -0.04% | +183.61% | |
| 8 | ✓ | Hookipa Pharma | Stock-Other | 2.44% | — | — | |
| 9 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 2.32% | -1.18% | — | |
| 10 | EQX | Equinox Gold CORP | Stock-Other | 2.06% | — | +30.86% | |
| 11 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 2.06% | -2.12% | — | |
| 12 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 2.00% | — | — | |
| 13 | SIL1EUR | Silvercrest Metals Inc | Stock-Other | 1.95% | — | — | |
| 14 | FNV | Franco-nevada CORP | Stock-Materials | 1.85% | -1.28% | — | |
| 15 | MQ8 | Mag Silver CORP | Stock-Other | 1.81% | — | +161.90% | |
| 16 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 1.76% | -0.25% | — | |
| 17 | KGC | Kinross Gold CORP | Stock-Materials | 1.68% | -1.89% | — | |
| 18 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 1.20% | +2.10% | — | |
| 19 | OCUL | Ocular Therapeutix Inc | Stock-Other | 1.13% | +2.45% | — | |
| 20 | V | Visa Inc-class A Shares | Stock-Financials | 0.84% | — | — | |
| 21 | SIL | Global X Silver Miners ETF | ETF-Commodities | 0.77% | — | -74.33% | |
| 22 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.73% | -0.52% | — | |
| 23 | CVS | Cvs Health CORP | Stock-Healthcare | 0.72% | — | — | |
| 24 | SLV | Ishares Silver Trust | ETF-Commodities | 0.69% | — | — | |
| 25 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.64% | -0.31% | — | |
| 26 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.63% | -0.06% | — | |
| 27 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.62% | — | — | |
| 28 | RGLD | Royal Gold Inc | Stock-Materials | 0.57% | -2.54% | — | |
| 29 | PM | Philip Morris International | Stock-Consumer Staples | 0.57% | -0.08% | — | |
| 30 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.53% | — | +62.32% | |
| 31 | NEWP | New Pacific Metals CORP | Stock-Other | 0.40% | -0.20% | — | |
| 32 | ✓ | Orgenesis, Inc. | Stock-Other | 0.32% | -0.01% | — | |
| 33 | IRD | Opus Genetics Inc | Stock-Other | 0.13% | — | — | |
| 34 | SKE | Skeena Resources LTD | Stock-Other | 0.11% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | APLT | Applied Therapeutics Inc | +8.4% | +1.83% | Add |
| 2 | GLD | Spdr Gold Shares | +4.1% | NEW | New buy |
| 3 | ✓ | Entera Bio LTD | +2.1% | — | Unchanged |
| 4 | FNV | Franco-nevada CORP | +1.9% | NEW | New buy |
| 5 | ALT | Altimmune Inc | +1.7% | +183.61% | Add |
| 6 | MQ8 | Mag Silver CORP | +0.9% | +161.90% | Add |
| 7 | SLV | Ishares Silver Trust | +0.7% | NEW | New buy |
| 8 | DEO | Diageo Plc-sponsored Adr | +0.6% | NEW | New buy |
| 9 | OCUL | Ocular Therapeutix Inc | +0.4% | — | Unchanged |
| 10 | EQX | Equinox Gold CORP | +0.4% | +30.86% | Add |
| 11 | MREO | Mereo Biopharma Group Pl-adr | +0.2% | +62.32% | Add |
| 12 | SKE | Skeena Resources LTD | +0.1% | NEW | New buy |
| 13 | ✓ | Orgenesis, Inc. | +0.1% | — | Unchanged |
| 14 | IRD | Opus Genetics Inc | -0.1% | — | Unchanged |
| 15 | SEA1EUR | Seabridge Gold Inc | -0.2% | — | Unchanged |
| 16 | AGI | Alamos Gold Inc-class A | -0.2% | — | Unchanged |
| 17 | ITA | Ishares U.s. Aerospace & Def | -0.2% | — | Unchanged |
| 18 | BAH | Booz Allen Hamilton Holdings | -0.2% | — | Unchanged |
| 19 | RGLD | Royal Gold Inc | -0.2% | — | Unchanged |
| 20 | V | Visa Inc-class A Shares | -0.2% | — | Unchanged |
| 21 | NOC | Northrop Grumman CORP | -0.2% | — | Unchanged |
| 22 | CVS | Cvs Health CORP | -0.2% | — | Unchanged |
| 23 | PM | Philip Morris International | -0.3% | — | Unchanged |
| 24 | NEWP | New Pacific Metals CORP | -0.4% | — | Unchanged |
| 25 | AEM | Agnico Eagle Mines LTD | -0.5% | — | Unchanged |
| 26 | KGC | Kinross Gold CORP | -0.5% | — | Unchanged |
| 27 | SIL1EUR | Silvercrest Metals Inc | -0.6% | — | Unchanged |
| 28 | BHVN | Biohaven Ltd. | -0.7% | — | Unchanged |
| 29 | WPM | Wheaton Precious Metals CORP | -0.7% | — | Unchanged |
| 30 | ✓ | Avadel Pharmaceuticals PLC ADR | -0.7% | — | Unchanged |
| 31 | TMO | Thermo Fisher Scientific Inc | -0.9% | EXIT | Sold out |
| 32 | ✓ | Hookipa Pharma | -1.3% | — | Unchanged |
| 33 | VRNA | Verona Pharma PLC - Adr | -1.3% | — | Unchanged |
| 34 | GDXJ | Vaneck Junior Gold Miners | -1.7% | EXIT | Sold out |
| 35 | GDX | Vaneck Gold Miners ETF | -2.4% | EXIT | Sold out |
| 36 | SIL | Global X Silver Miners ETF | -3.4% | -74.33% | Trim |
| 37 | ALDX | Aldeyra Therapeutics Inc | -4.8% | — | Unchanged |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $214.3M across 34 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including APLT, BHVN, ALDX) accounted for 46.4% of total reported equity market value during Q1 2024.
Top New Position Initiated
GLD
市值: $6.6M
Top Position Liquidated / Trimmed
GDX
前期市值: $2.8M
During Q1 2024, Knoll Capital Management, LLC's top holdings by market value included APLT (23.6%)、BHVN (16.7%)、ALDX (11.1%). The largest single position, APLT, represented 23.6% of total portfolio value.
In Q1 2024, Knoll Capital Management, LLC made 14 total portfolio adjustments, initiating 5 new buys, adding to 5 positions, trimming 1 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.